Frontiers in Oncology | Thoracic Oncology

Case Report

Published on 27 Mar 2024

Outcomes of non-small cell lung cancer patients with non-V600E BRAF mutations: a series of case reports and literature review

in Thoracic Oncology

Raluca Lazar
Cathie Fischbach
Roland Schott
Laura Somme

Frontiers in Oncology

doi 10.3389/fonc.2024.1307882

3,875 views
6 citations

Original Research

Published on 27 Mar 2024

A real-world retrospective, observational study of first-line pembrolizumab plus chemotherapy for metastatic non-squamous non-small cell lung cancer with PD-L1 tumor proportion score < 50% (PEMBROREAL)

in Thoracic Oncology

Alessandro Cafaro
Flavia Foca
Oriana Nanni
Marco Chiumente
Marina Coppola
Paolo Baldo
Sabrina Orzetti
Fiorenza Enrico
Vito Ladisa
Rosa Lerose

Frontiers in Oncology

doi 10.3389/fonc.2024.1351995

5,390 views
5 citations

Review

Published on 27 Mar 2024

A review of perioperative treatment strategies with immunotherapy and tyrosine kinase inhibitors in resectable and stage IIIA-N2 non-small cell lung cancer

in Thoracic Oncology

Madeleine B. Hopson
Sawsan Rashdan

Frontiers in Oncology

doi 10.3389/fonc.2024.1373388

3,922 views
1 citation

Case Report

Published on 25 Mar 2024

Case report: Molecular profiling facilitates the diagnosis of a challenging case of lung cancer with choriocarcinoma features

in Thoracic Oncology

Hui Li
Xin Hu
Matthew S. Ning
Gregory N. Fuller
John M. Stewart
Jared C. Gilliam
Jia Wu
Xiuning Le
Ara A. Vaporciyan
J. Jack Lee

Frontiers in Oncology

doi 10.3389/fonc.2024.1324057

3,184 views

Case Report

Published on 25 Mar 2024

Case report: EGFR fusion mutation combined with EGFR amplification responds to EGFR-TKI therapy

in Thoracic Oncology

Zhulin Wang
Chunyao Huang
Wenbo Fan
Shaowu Sun
Kaiyuan Li
Xu Liu
Jiangtao Pu
Guoqing Zhang
Xiangnan Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1347282

3,207 views

Editorial

Published on 20 Mar 2024

Editorial: Case reports in thoracic oncology: 2022

in Thoracic Oncology

Yaron Perry

Frontiers in Oncology

doi 10.3389/fonc.2024.1369799

1,803 views

Original Research

Published on 20 Mar 2024

Preoperative systemic immune-inflammation index-based nomogram for lung carcinoma following microwave ablation -a real world single center study

in Thoracic Oncology

Jing Wang
Song-ping Cui
Qing Zhao
Ya Gao
Ying Ji
Yi Liu
Jin-bai Miao
Yi-li Fu
Bin Hu

Frontiers in Oncology

doi 10.3389/fonc.2024.1305262

2,027 views
7 citations

Brief Research Report

Published on 20 Mar 2024

Understanding the perceived benefits, barriers, and cues to action for lung cancer screening among Latinos: A qualitative study

in Thoracic Oncology

Edgar I. Alaniz-Cantú
Kalese Goodwin
London Smith
Eliany Acosta
Arlette Chávez-Iñiguez
Mary Jo Evans
Marcela Gaitán
Fang Lei
Reza Yousefi-Nooraie
Kevin A. Fiscella

Frontiers in Oncology

doi 10.3389/fonc.2024.1365739

3,138 views
10 citations

Original Research

Published on 20 Mar 2024

Radiomics model based on intratumoral and peritumoral features for predicting major pathological response in non-small cell lung cancer receiving neoadjuvant immunochemotherapy

in Thoracic Oncology

Dingpin Huang
Chen Lin
Yangyang Jiang
Enhui Xin
Fangyi Xu
Yi Gan
Rui Xu
Fang Wang
Haiping Zhang
Kaihua Lou

Frontiers in Oncology

doi 10.3389/fonc.2024.1348678

4,355 views
17 citations

Original Research

Published on 19 Mar 2024

Plasma metabolomics reveals risk factors for lung adenocarcinoma

in Thoracic Oncology

Mengjie Yu
Wei Wen
Yue Wang
Xia Shan
Xin Yi
Wei Zhu
Jiye Aa
Guangji Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1277206

3,005 views
4 citations

Original Research

Published on 19 Mar 2024

Anti-angiogenic therapy or immunotherapy? A real-world study of patients with advanced non-small cell lung cancer with EGFR/HER2 exon 20 insertion mutations

in Thoracic Oncology

Jiaqi Li
Mengqing Xie
Ruiying Zhao
Huiping Qiang
Qing Chang
Jialin Qian
Haijiao Lu
Yinchen Shen
Yuchen Han
Chunxia Su

Frontiers in Oncology

doi 10.3389/fonc.2024.1357231

3,954 views
5 citations

Case Report

Published on 18 Mar 2024

Case report: Complex left-carina resection: three-year single-center experience

in Thoracic Oncology

Simone Tombelli
Domenico Viggiano
Ottavia Salimbene
Marco Trigiani
Luca Voltolini
Alessandro Gonfiotti

Frontiers in Oncology

doi 10.3389/fonc.2024.1367311

1,725 views

Case Report

Published on 12 Mar 2024

Case report: Bronchoscopic intervention for rare benign airway tumors: a report of 4 cases and literature review

in Thoracic Oncology

Zhifang Cui
Jinhong Wang
Hongwu Wang
Lei Li
Xiaohui Si
Yanbin Zhang
Heng Zou

Frontiers in Oncology

doi 10.3389/fonc.2024.1357982

4,266 views
1 citation

Original Research

Published on 11 Mar 2024

The application of artificial intelligence for Rapid On-Site Evaluation during flexible bronchoscopy

in Thoracic Oncology

Shuang Yan
Yongfei Li
Lei Pan
Hua Jiang
Li Gong
Faguang Jin

Frontiers in Oncology

doi 10.3389/fonc.2024.1360831

4,999 views
18 citations

Original Research

Published on 11 Mar 2024

Diagnosis of benign and malignant peripheral lung lesions based on a feature model constructed by the random forest algorithm for grayscale and contrast-enhanced ultrasound

in Thoracic Oncology

Hong Wei
Yichun Wang
Jinyao Li
Yanyan Wang
Longdi Lu
Jiawei Sun
Xiaolei Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1352028

2,162 views
3 citations

Original Research

Published on 11 Mar 2024

Beneficial implications of adjuvant chemotherapy for stage IB lung adenocarcinoma exhibiting elevated SUVmax in FDG-PET/CT: a retrospective study from a single center

in Thoracic Oncology

Miao Huang
Bing Liu
Xiang Li
Nan Li
Xin Yang
Yaqi Wang
Shanyuan Zhang
Fangliang Lu
Shaolei Li
Shi Yan

Frontiers in Oncology

doi 10.3389/fonc.2024.1367200

1,909 views
1 citation

Editorial

Published on 11 Mar 2024

Editorial: Pulmonary fibrosis and lung carcinogenesis: do myofibroblasts and cancer-associated fibroblasts share a common identity?

in Thoracic Oncology

Daniela de Totero
Emanuela Barisione
Enrico Clini

Frontiers in Oncology

doi 10.3389/fonc.2024.1389532

1,872 views
2 citations

Original Research

Published on 08 Mar 2024

Frontline pembrolizumab monotherapy for metastatic non-small cell lung cancer with PD-L1 expression ≥50%: real-world outcomes in a US community oncology setting

in Thoracic Oncology

Shirish M. Gadgeel
Pragya Rai
Srinivas Annavarapu
Sartaj Alam
Jerome H. Goldschmidt
Howard (Jack) West
Melissa Santorelli
Renata Eiras Martins

Frontiers in Oncology

doi 10.3389/fonc.2024.1298603

4,888 views
1 citation

Systematic Review

Published on 08 Mar 2024

Application of three-dimensional technology in video-assisted thoracoscopic surgery sublobectomy

in Thoracic Oncology

Xinyu Zhang
Di Yang
Linqian Li
Jianing Wang
Si Liang
Peng Li
Zhe Han
Xiaodong Wang
Ke Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1280075

3,544 views
5 citations

Review

Published on 07 Mar 2024

Ferroptosis in lung cancer: dual role, multi-level regulation, and new therapeutic strategies

in Thoracic Oncology

Yunbin Li
Xiaosong Li
Jian Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1360638

4,414 views
10 citations

Study Protocol

Published on 07 Mar 2024

Efficacy and safety of pembrolizumab as first-line treatment for advanced non-small cell lung cancer complicated with chronic obstructive pulmonary disease: protocol for a prospective, single-arm, single-center, phase II clinical trial

in Thoracic Oncology

Weigang Dong
Yan Yin
Bin Liu
Yan Jiang
Lei Wang
Dongsheng Shi
Jianwen Qin

Frontiers in Oncology

doi 10.3389/fonc.2024.1179232

3,389 views
3 citations

Original Research

Published on 05 Mar 2024

Lung adenocarcinoma: selection of surgical approaches in solid adenocarcinoma from the viewpoint of clinicopathologic features and tumor microenvironmental heterogeneity

in Thoracic Oncology

Xiao Li
Zhen Gao
Haixiao Diao
Chenran Guo
Yue Yu
Shang Liu
Zhen Feng
Zhongmin Peng

Frontiers in Oncology

doi 10.3389/fonc.2024.1326626

2,768 views
3 citations

Case Report

Published on 01 Mar 2024

Case report: Primary pulmonary low grade fibromyxoid sarcoma progressing to dedifferentiation: probably due to TP53 driver mutation

in Thoracic Oncology

Jiawen Zhang
Haisheng Fang
Xiaomei Zhu
Chenchen Yao
Qinhe Fan
Qixing Gong

Frontiers in Oncology

doi 10.3389/fonc.2024.1329264

2,530 views
2 citations

Case Report

Published on 27 Feb 2024

Remarkable response to third-generation EGFR-TKI plus crizotinib in a patient with pulmonary adenocarcinoma harboring EGFR and ROS1 co-mutation: a case report

in Thoracic Oncology

Zhiming Wu
Zelin Zhang
Dongdong Zhang
Zengyan Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1357230

2,520 views
6 citations

1,916 articles

articles

Outcomes of non-small cell lung cancer patients with non-V600E BRAF mutations: a series of case reports and literature review

A real-world retrospective, observational study of first-line pembrolizumab plus chemotherapy for metastatic non-squamous non-small cell lung cancer with PD-L1 tumor proportion score < 50% (PEMBROREAL)

A review of perioperative treatment strategies with immunotherapy and tyrosine kinase inhibitors in resectable and stage IIIA-N2 non-small cell lung cancer

Case report: Molecular profiling facilitates the diagnosis of a challenging case of lung cancer with choriocarcinoma features

Case report: EGFR fusion mutation combined with EGFR amplification responds to EGFR-TKI therapy

Editorial: Case reports in thoracic oncology: 2022

Preoperative systemic immune-inflammation index-based nomogram for lung carcinoma following microwave ablation -a real world single center study

Understanding the perceived benefits, barriers, and cues to action for lung cancer screening among Latinos: A qualitative study

Radiomics model based on intratumoral and peritumoral features for predicting major pathological response in non-small cell lung cancer receiving neoadjuvant immunochemotherapy

Plasma metabolomics reveals risk factors for lung adenocarcinoma

Anti-angiogenic therapy or immunotherapy? A real-world study of patients with advanced non-small cell lung cancer with EGFR/HER2 exon 20 insertion mutations

Case report: Complex left-carina resection: three-year single-center experience

Case report: Bronchoscopic intervention for rare benign airway tumors: a report of 4 cases and literature review

The application of artificial intelligence for Rapid On-Site Evaluation during flexible bronchoscopy

Diagnosis of benign and malignant peripheral lung lesions based on a feature model constructed by the random forest algorithm for grayscale and contrast-enhanced ultrasound

Beneficial implications of adjuvant chemotherapy for stage IB lung adenocarcinoma exhibiting elevated SUVmax in FDG-PET/CT: a retrospective study from a single center

Editorial: Pulmonary fibrosis and lung carcinogenesis: do myofibroblasts and cancer-associated fibroblasts share a common identity?

Frontline pembrolizumab monotherapy for metastatic non-small cell lung cancer with PD-L1 expression ≥50%: real-world outcomes in a US community oncology setting

Application of three-dimensional technology in video-assisted thoracoscopic surgery sublobectomy

Ferroptosis in lung cancer: dual role, multi-level regulation, and new therapeutic strategies

Efficacy and safety of pembrolizumab as first-line treatment for advanced non-small cell lung cancer complicated with chronic obstructive pulmonary disease: protocol for a prospective, single-arm, single-center, phase II clinical trial

Lung adenocarcinoma: selection of surgical approaches in solid adenocarcinoma from the viewpoint of clinicopathologic features and tumor microenvironmental heterogeneity

Case report: Primary pulmonary low grade fibromyxoid sarcoma progressing to dedifferentiation: probably due to TP53 driver mutation

Remarkable response to third-generation EGFR-TKI plus crizotinib in a patient with pulmonary adenocarcinoma harboring EGFR and ROS1 co-mutation: a case report